<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01432067</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2010/23</org_study_id>
    <nct_id>NCT01432067</nct_id>
  </id_info>
  <brief_title>Physical Activity Advices to Prevent Loss of Autonomy in Cancer Treated Elderly Patients. An Intervention Randomized Study</brief_title>
  <acronym>CAPADOGE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will propose to older cancer patients with good prognosis (curative care) a&#xD;
      randomized trial of adapted physical activity during one year. To increase generalisation of&#xD;
      the intervention the investigators intend to compare the PNNS advices (the French National&#xD;
      Nutrition and Health Program) to a program targeted on the own capacities of each patient.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Long-term evolution of successful-treated older patients is not well-known except for&#xD;
      survival. They seem more affected by physical than psychological problems. The combined&#xD;
      effects of aging, cancer, and treatments on muscle function could have hindered their usual&#xD;
      physical activity. Cancer is associated with frailty. Fried and coll have defined a frailty&#xD;
      phenotype as a combination of 3 or more of 5 conditions: exhaustion, loss of weight,&#xD;
      decreased muscle strength, slow gait speed and low physical activity. Frail subjects have a&#xD;
      higher risk of physical or cognitive disability and death. An intervention able to prevent&#xD;
      frailty is of great interest for the older cancer patient and their quality of life. An&#xD;
      intervention consisting of phone-program in physical activity has been associated with a&#xD;
      decrease in self-reported disability in five-year obese survivors from cancer.&#xD;
&#xD;
      Patients will be randomized in two arms (1:1 ratio). Arm 1: Physical activity advices&#xD;
      according to a program adapted to physical status of the patient assessed using SPPB (short&#xD;
      physical performance battery) and the IPAQ questionnaire. A monthly phone support during one&#xD;
      year will be performed by an adapted physical activity instructor and delivery of PNNS guide&#xD;
      for subjects older than 55 y old. Arm 2: Delivery of PNNS guide for subjects older than 55&#xD;
      year old: recommendation of 1/2 hour physical activity of any kind.&#xD;
&#xD;
      Each patient will be followed during 2 years: First visit (V1) will take place before&#xD;
      treatment. The subsequent visits will take place at 3 months (V2), 6 months (V3), 1 year&#xD;
      (V4), 18 months (V5) and 2 years (V6), in which patients will complete questionnaires (IPAQ,&#xD;
      QLQ-C30, one day dietary intakes), have clinical examinations (weight, performance status/&#xD;
      ECOG) and will be tested for physical facilities (SPPB, micro-fet2). These evaluations will&#xD;
      be completed by the MMS / Fluency tests and the covered distance during 6 minutes at V1, V3,&#xD;
      and V4.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 4, 2011</start_date>
  <completion_date type="Actual">June 10, 2016</completion_date>
  <primary_completion_date type="Actual">June 10, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SPPB Score</measure>
    <time_frame>1 year</time_frame>
    <description>The main outcome will be the proportion of subjects with a one-year decreased SPPB score of one point or more in 12.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive skills</measure>
    <time_frame>2 years</time_frame>
    <description>MMS test, verbal fluency</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>2 years</time_frame>
    <description>IPAQ, QLQ-C30, ADL, performance status (ECOG)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nutritional status</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking distance over 6 minutes</measure>
    <time_frame>inclusion, 6 months and 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>isometric muscle strength measures of upper and lower limbs</measure>
    <time_frame>2 years</time_frame>
    <description>microfet2 test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>weight</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SPPB score</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">302</enrollment>
  <condition>Cancer</condition>
  <condition>Elderly Population</condition>
  <arm_group>
    <arm_group_label>Adaptated physical activity</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Physical activity advices adaptated to physical status of patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard physical activity</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Daily physical activities based on a standard guide</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adapted physical activity</intervention_name>
    <description>Physical activity advices according to a program adapted to physical status of the patient.</description>
    <arm_group_label>Adaptated physical activity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Classic physical activities</intervention_name>
    <description>Daily physical activities based on a standard guide</description>
    <arm_group_label>Standard physical activity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  70 years old or older&#xD;
&#xD;
          -  Curative cares for cancer by chemotherapy and/ or surgery and/or hormonotherapy and/&#xD;
             or radiotherapy&#xD;
&#xD;
          -  Patient with histologically proven lymphoma or carcinoma :&#xD;
&#xD;
               -  Colon, rectum or anal canal Cancer&#xD;
&#xD;
               -  Breast Cancer&#xD;
&#xD;
               -  Esophageal cancer&#xD;
&#xD;
               -  Otolaryngology Cancer&#xD;
&#xD;
               -  Kidney cancer&#xD;
&#xD;
               -  hepatocellular carcinoma&#xD;
&#xD;
               -  Stomach Cancer&#xD;
&#xD;
               -  Pancreatic cancer&#xD;
&#xD;
               -  Bile duct cancer&#xD;
&#xD;
               -  Ovarian Cancer&#xD;
&#xD;
               -  All lymphoma diffuse large B-cell and all peripheral T-cells lymphomas&#xD;
&#xD;
               -  All low-grade lymphoma: lymphocytes, lymphocytes and plasma cells, follicular,&#xD;
                  mantle, marginal zone (MALT and others)&#xD;
&#xD;
               -  Prostate cancer&#xD;
&#xD;
               -  Bladder Cancer&#xD;
&#xD;
               -  Lung cancer&#xD;
&#xD;
               -  adenocarcinoma of unknown primary origin compatible with previous quoted origin&#xD;
&#xD;
          -  Performance status (ECOG) &lt;4&#xD;
&#xD;
          -  Patient who had given oral consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Palliative cares for cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle BOURDEL MARCHASSON, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adélaïde DOUSSAU, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital, Bordeaux, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Bordeaux - Hôpital Saint André</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Dax</name>
      <address>
        <city>Dax</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret, CLCC Lille</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Limoges, Hôpital Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Mont de Marsan</name>
      <address>
        <city>Mont de Marsan</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux - hôpital Xavier Arnozan</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut jean Godinot, CLCC Reims</name>
      <address>
        <city>Reims</city>
        <zip>51056</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Senlis</name>
      <address>
        <city>Senlis</city>
        <zip>60309</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Alexis Vautrin CLCC Nancy</name>
      <address>
        <city>Vandœuvre-Les-Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nancy hôpital adulte du brabois</name>
      <address>
        <city>Vandœuvre-Les-Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <study_first_submitted>September 8, 2011</study_first_submitted>
  <study_first_submitted_qc>September 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2011</study_first_posted>
  <last_update_submitted>November 7, 2017</last_update_submitted>
  <last_update_submitted_qc>November 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>geriatry</keyword>
  <keyword>curative care</keyword>
  <keyword>physical activity</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

